Insmed (INSM) Tax Rate Growth (5y) (2016 - 2026)

Insmed (INSM) Tax Rate Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Insmed 22.73 Bn 21.51 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -71.00
Dec 31, 2025 13.00
Sep 30, 2025 15.00
Jun 30, 2025 26.00
Dec 31, 2024 10.00
Sep 30, 2024 -30.00
Jun 30, 2024 -12.00
Mar 31, 2024 -11.00
Dec 31, 2023 -47.00
Sep 30, 2023 -29.00
Jun 30, 2023 -15.00
Dec 31, 2022 -63.00
Sep 30, 2022 -22.00
Jun 30, 2022 -44.00
Mar 31, 2022 -33.00
Dec 31, 2021 12.00
Sep 30, 2021 230.00
Jun 30, 2021 -46.00
Mar 31, 2021 -14.00
Dec 31, 2019 -2,614.00